# Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

> **NCT01443351** · — · WITHDRAWN · sponsor: **Zealand University Hospital**

## Conditions studied

- Idiopathic Thrombocytopenic Purpura

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01443351
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** failure to recruit patients
- **Last updated:** 2019-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443351, "Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01443351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*